Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,918.50
(
-0.14%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.00
(
0.35%
)
Bitcoin
75,932.96
(
0.05%
)
News Focus
News Focus

Replies to post #184965 on Innovation Pharmaceuticals Inc (IPIX)

Replies to #184965 on Innovation Pharmaceuticals Inc (IPIX)
icon url

Bruinfan4ever

06/08/17 9:53 PM

#184969 RE: scottsmith #184965

If clinical data is not good for B and P, there is going to be a lot more problems than a R/S.
icon url

TheDane

06/08/17 10:08 PM

#184974 RE: scottsmith #184965

Devious.
icon url

sox040713

06/08/17 10:19 PM

#184976 RE: scottsmith #184965

If all four trials fail, RS will be the least of my concerns. Besides, you aren't going to hear a CEO guarantee something in a CC.
icon url

DaubersUP

06/08/17 10:25 PM

#184977 RE: scottsmith #184965

which is not on the table."